Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04735627 · ClinicalTrials.gov registry record · NA

Real-Time Levodopa Level Monitoring in Parkinson Disease

A NA study of Parkinson Disease, sponsored by University of California, San Diego.

Recruiting
Registry status
NA
Development phase
20
Enrollment target
1
Study location

NCT04735627 is a NA study of Parkinson Disease that is actively recruiting participants, run by University of California, San Diego. The registered enrollment target is 20 participants, below the 5,326-participant average among 297 other Parkinson Disease trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04735627, a NA study of Parkinson Disease, is actively recruiting participants, sponsored by University of California, San Diego.

RECRUITING
Registry status
NA
Development phase
20 participants
Enrollment target
1
Study location

Study Summary

This project aims to develop a minimally invasive sensor device to monitor levodopa levels in real time. We will test the accuracy, tolerability, and safety of this device in people with Parkinson disease.

Conditions Studied

Interventions

  • DEVICE Levodopameter

Study Locations (1)

California

  • University of California San DIego - San Diego

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2021-12-07
Est. Completion 2028-02
Phase NA

Sponsor

University of California, San Diego

775 total trials

What the Registry Record Tells You About NCT04735627

The ClinicalTrials.gov registry entry for NCT04735627 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 5,326-participant average among 297 other Parkinson Disease trials with a reported enrollment target (100% lower). The listed sponsor is University of California, San Diego, which has 775 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Parkinson Disease appearing as the primary indexed condition, and to 1 intervention - of which Levodopameter is the first listed.

NCT04735627 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT04735627 about?

NCT04735627 is a clinical study titled "Real-Time Levodopa Level Monitoring in Parkinson Disease". This project aims to develop a minimally invasive sensor device to monitor levodopa levels in real time. We will test the accuracy, tolerability, and safety of this device in people with Parkinson disease.

What is the current status of trial NCT04735627?

This trial is currently recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2021-12-07. Estimated completion is 2028-02.

What conditions does trial NCT04735627 study?

This clinical trial studies the following conditions: Parkinson Disease.

What interventions are being tested in trial NCT04735627?

The interventions under investigation include: Levodopameter (DEVICE).

Who is sponsoring clinical trial NCT04735627?

This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04735627 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Parkinson Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.